PFIZER INC.
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
- Conditions
- Carcinoma, Squamous CellCarcinoma, AdenosquamousCarcinoma, Large CellCarcinoma, Non-Small-Cell Lung
- Interventions
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2014-01-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 681
- Registration Number
- NCT00596830
- Locations
- πΊπ¦
Pfizer Investigational Site, Sumy, Ukraine
Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking
- Conditions
- Smoking Cessation
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 593
- Registration Number
- NCT00594204
- Locations
- π»πͺ
Pfizer Investigational Site, Caracas, Venezuela
A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
- Conditions
- Non-Small Cell Lung Cancer ALK-positiveSystemic Anaplastic Large-Cell LymphomaNon-Small Cell Lung Cancer c-Met DependentNon-Small Cell Lung Cancer ROS Marker PositiveAdvanced Malignancies Except Leukemia
- Interventions
- First Posted Date
- 2008-01-03
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 596
- Registration Number
- NCT00585195
- Locations
- πΊπΈ
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
πΊπΈUniversity of Chicago, Chicago, Illinois, United States
πΊπΈThe James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
RN624 In Adult Patients With Chronic Low Back Pain
- Conditions
- Low Back Pain
- Interventions
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 220
- Registration Number
- NCT00584870
- Locations
- πΊπΈ
Wake Internal Medicine Consultants, Inc., Raleigh, North Carolina, United States
πΊπΈPinnacle Research Group LLC, Anniston, Alabama, United States
πΊπΈRadiant Research - Phoenix Southeast, Chandler, Arizona, United States
Treatment Use Study for Advanced Melanoma.
- Conditions
- Advanced Unresectable Melanoma
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2009-12-14
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00584493
Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy
- First Posted Date
- 2007-12-27
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 120
- Registration Number
- NCT00581555
Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2012-04-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 164
- Registration Number
- NCT00580125
- Locations
- πΊπ¦
Pfizer Investigational Site, Lugansk, Ukraine
Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2009-09-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 47
- Registration Number
- NCT00580190
- Locations
- πΊπΈ
Pfizer Investigational Site, New Haven, Connecticut, United States
Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones
- Conditions
- Obesity
- Interventions
- Drug: CE-326,597Drug: Placebo
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2010-01-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 41
- Registration Number
- NCT00576589
- Locations
- πΊπΈ
Pfizer Investigational Site, Willingboro, New Jersey, United States
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 502
- Registration Number
- NCT00574873
- Locations
- πΊπΈ
Pacific Cancer Medical Center Inc, Anaheim, California, United States
πΊπΈRobert A Moss, MD, FACP, Inc, Fountain Valley, California, United States
πΊπΈSiouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States